Osaka, Japan & Cambridge, Mass., United States: − Approval Based on Results from Positive, Global, Phase 3 FRESCO-2 Trial −
TOKYO, Japan: Neu REFIX Beta glucan, made in Japan has received both Rare Pediatric Disease Designation (RPDD) and Orphan Drug
Uniwater has entered into an agreement to acquire Biowater Technology, a Norwegian specialist in innovative water treatment technologies and projects.
Though World Asthma Day is observed once a year on May 2, asthma is top-of-mind every day for Stavros Garantziotis, M.D., who serves as medical
To reduce the burden of epilepsy in economically disadvantaged communities, a city-based private hospital on Saturday launched an Epilepsy Prevention and Integrated Care (EPIC) programme.
Darmstadt, Germany: Phase IV studies demonstrate the consistent safety and high efficacy of MAVENCLAD on NEDA-3, MRI and cognition
Chesterbrook, Pa., United States: – Breakthrough Therapy designation for NTX-001 granted by FDA – Preparation is underway for the Phase
Socially Bharat is your comprehensive source for Social news, NGO’s, and expert insights from across India.
Copyright© 2025 Creative Bharat Powered By A Buzz Company